tradearcher

(D) A bit early to consider long, esp. with earnings near.

NASDAQ:BLUE   bluebird bio, Inc.
Slope of ema50 is nearly flat and ema200 is mildly bearish, meaning price action at a possible inflection point near earnings. Will see $55 if bullish momentum continues. Otherwise retesting March lows for support is within it's ATR. Obey your rules.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。